Literature DB >> 24832003

Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?

Kristina S Boye1, Louis S Matza, David H Feeny, Joseph A Johnston, Lee Bowman, Jessica B Jordan.   

Abstract

In recent years, the time trade-off (TTO) method, most commonly with a 10-year time horizon, has been the most frequently used approach for direct health state utility assessment, likely due to National Institute for Health and Care Excellence (NICE) preference for comparability with the EQ-5D, which has a utility scoring algorithm derived via this method. Although comparability to previous utility studies is important, there are situations when the TTO method may not be appropriate. The purpose of the current review is to highlight challenges to the TTO method. Five challenges to the TTO method are discussed: mild health states, small differences among health states, temporary health states, pediatric health states, and assessment of samples with particular characteristics. Some of these challenges are associated with the 10-year time horizon, while other situations may raise issues for TTO methods regardless of the time horizon. Alternative approaches for valuing health states are suggested.

Keywords:  QALY; TTO; patient preference; standard gamble; time horizon; time trade-off; utility

Mesh:

Year:  2014        PMID: 24832003     DOI: 10.1586/14737167.2014.912562

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  12 in total

Review 1.  Experience-Based Values: A Framework for Classifying Different Types of Experience in Health Valuation Research.

Authors:  Patricia Cubi-Molla; Koonal Shah; Kristina Burström
Journal:  Patient       Date:  2018-06       Impact factor: 3.883

2.  Increasing respondent engagement in composite time trade-off tasks by imposing three minimum trade-offs to improve data quality.

Authors:  Ruixuan Jiang; Thomas Kohlmann; Todd A Lee; Axel Mühlbacher; James Shaw; Surrey Walton; A Simon Pickard
Journal:  Eur J Health Econ       Date:  2020-08-28

3.  Community perspectives on difference of sex development (DSD) diagnoses: A crowdsourced survey.

Authors:  M Hassan Alkazemi; Ashley W Johnston; Diane Meglin; Deanna Adkins; Jonathan C Routh
Journal:  J Pediatr Urol       Date:  2020-04-27       Impact factor: 1.830

4.  Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China.

Authors:  Liu Liu; Shunping Li; Yue Zhao; Jianglin Zhang; Gang Chen
Journal:  Qual Life Res       Date:  2018-02-28       Impact factor: 4.147

5.  EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes.

Authors:  Mark Oppe; Kim Rand-Hendriksen; Koonal Shah; Juan M Ramos-Goñi; Nan Luo
Journal:  Pharmacoeconomics       Date:  2016-10       Impact factor: 4.981

Review 6.  Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes.

Authors:  Jayne Smith-Palmer; Jay P Bae; Kristina S Boye; Kirsi Norrbacka; Barnaby Hunt; William J Valentine
Journal:  Clinicoecon Outcomes Res       Date:  2016-10-07

7.  Health-Related Quality of Life Among Liver Disorder Patients in Northern India.

Authors:  Yashika Chugh; Swati Katoch; Deepshikha Sharma; Pankaj Bahuguna; Ajay Duseja; Manmeet Kaur; Radha Krishan Dhiman; Shankar Prinja
Journal:  Indian J Community Med       Date:  2022-03-16

8.  An effectiveness-implementation hybrid trial study protocol targeting posttraumatic stress disorder and comorbidity.

Authors:  Douglas F Zatzick; Joan Russo; Doyanne Darnell; David A Chambers; Lawrence Palinkas; Erik Van Eaton; Jin Wang; Leah M Ingraham; Roxanne Guiney; Patrick Heagerty; Bryan Comstock; Lauren K Whiteside; Gregory Jurkovich
Journal:  Implement Sci       Date:  2016-04-30       Impact factor: 7.327

Review 9.  A systematic literature review of health state utility values in head and neck cancer.

Authors:  Michela Meregaglia; John Cairns
Journal:  Health Qual Life Outcomes       Date:  2017-09-02       Impact factor: 3.186

10.  Health state utilities for metastatic breast cancer in Taiwan.

Authors:  Tzu-Chun Chou; Shao-Chin Chiang; Yu Ko
Journal:  Breast       Date:  2020-03-06       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.